Molecular determinants of context-dependent progesterone receptor action in breast cancer
about
Deciphering the divergent roles of progestogens in breast cancer.Heregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer Growth.Antiprogestins in gynecological diseases.Progesterone action in breast, uterine, and ovarian cancers.Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cellsElevation of SIPL1 (SHARPIN) Increases Breast Cancer RiskIdentification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells.Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L1 Expression.Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo.Progesterone receptor blockade in human breast cancer cells decreases cell cycle progression through G2/M by repressing G2/M genes.Neonatal Progesterone Programs Adult Uterine Responses to Progesterone and Susceptibility to Uterine DysfunctionProgesterone regulates the proliferation of breast cancer cells - in vitro evidence.Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapiesProliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutations.Androgen receptor splice variants in the era of enzalutamide and abiraterone.Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial.TADs as modular and dynamic units for gene regulation by hormones.Biomarker assessment and molecular testing for prognostication in breast cancer.Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast Cancer.Control of Progesterone Receptor-A Transrepressive Activity in Myometrial Cells: Implications for the Control of Human Parturition.Steroid Hormone Receptor Positive Breast Cancer Patient-Derived Xenografts.Anti-Tumoral Effects of Anti-Progestins in a Patient-Derived Breast Cancer Xenograft Model.Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.O-GlcNAcylation in women's cancers: breast, endometrial and ovarian.O-GlcNAc-Dependent Regulation of Progesterone Receptor Function in Breast Cancer.Sex Steroid-Mediated Control of Oviductal Function in Cattle.Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling.Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III.Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort.
P2860
Q30240711-0F8F2961-DC4E-491A-A35A-BDB9732531D8Q33631532-FB952537-9B00-4C36-A598-4BC0ED0CF704Q34587636-F788D023-D138-439E-87C1-6931BB9A7847Q35108906-6101AFAE-896A-414D-B008-95BB9FD506B5Q35551964-26362E0C-6027-41E3-BDCA-68A711DC0CC5Q35625533-50018866-A94F-4708-9233-C36A1A608752Q35650240-B0C76021-3E89-40A2-B6F1-579FF48A6B19Q35810608-C2D2D3ED-07FF-4C0A-B002-825A31B584E7Q35969254-1E11A5D0-FD41-4A33-A82D-9AA046FF8CB7Q36027031-A67764C9-E1D7-4500-89C0-B37786355C51Q36107514-89C220BD-BBA0-466D-AC91-F007C22304F6Q36277982-9C35CA4C-2144-4D37-9371-DD39177353BDQ37186618-F00DEAAB-2F3E-4CDE-A41A-A7070D7DA8A2Q37564411-A8702AF8-D38A-424F-919A-72F59B073885Q38232413-645DE0A0-8963-4588-868B-04292BBC5EB5Q38386693-A3B890AA-7DFC-4DBD-B014-31DC28974CFBQ38503197-628E0AC4-9F9D-4FF5-B0E6-922E43320CE2Q38696790-07EF69FE-40A0-4B24-978B-E5A253A73750Q38697912-87EE5856-4DBE-468D-9EDB-2B0E3C5024DDQ38698288-47A40D42-805D-4587-966C-BB8472E6D7B0Q38735015-75FC68CE-E5B1-40F0-AA25-C9F4061C2E21Q38789039-8C0D7116-9BF2-4197-ADE5-4ABE3F614F83Q47394260-9FF93CED-0A11-42FE-982F-42F7C6159234Q47414275-61D724FD-924A-470A-BE56-42D63F55F7E9Q47774103-613C4B77-84EE-4C62-A70F-00CDA1AD059CQ48115160-0CCE5A8C-F6B5-4F78-B7AA-E4637630F27CQ50053097-054FA8A2-32A7-4C4C-8324-C13EC3E402B3Q50879143-26932484-54FD-45E0-8F1B-5ADDE44F09C1Q54330083-59C5F77E-BBD8-40B7-A7F5-177C0F517460
P2860
Molecular determinants of context-dependent progesterone receptor action in breast cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Molecular determinants of context-dependent progesterone receptor action in breast cancer
@ast
Molecular determinants of context-dependent progesterone receptor action in breast cancer
@en
Molecular determinants of context-dependent progesterone receptor action in breast cancer
@nl
type
label
Molecular determinants of context-dependent progesterone receptor action in breast cancer
@ast
Molecular determinants of context-dependent progesterone receptor action in breast cancer
@en
Molecular determinants of context-dependent progesterone receptor action in breast cancer
@nl
prefLabel
Molecular determinants of context-dependent progesterone receptor action in breast cancer
@ast
Molecular determinants of context-dependent progesterone receptor action in breast cancer
@en
Molecular determinants of context-dependent progesterone receptor action in breast cancer
@nl
P2860
P921
P3181
P356
P1433
P1476
Molecular determinants of context-dependent progesterone receptor action in breast cancer
@en
P2093
Carol A Lange
Christy R Hagan
P2860
P2888
P3181
P356
10.1186/1741-7015-12-32
P407
P5008
P577
2014-02-20T00:00:00Z
P5875
P6179
1051720039